Literature DB >> 6788281

Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis.

S B Sundqvist, U Hedner, H K Kullenberg, S E Bergentz.   

Abstract

Sixty consecutive patients with phlebographically verified deep venous thrombosis of the upper arm were studied for disorders of coagulation and fibrinolysis. No appreciable increase in abnormalities of the factor VIII complex, antithrombin III, or inhibitors of activators of fibrinolysis were found. A decreased fibrinolytic defence mechanism, evident either as a deficient release capacity of fibrinolytic activators from the vein during stasis or as decreased fibrinolytic activity in the vein wall as determined histochemically, was found in 26 out of 53 patients studied (49%). It is concluded that deep venous thrombosis of the upper arm is a multifactorial disease. An impaired fibrinolytic defence mechanism is one of the factors that may be of pathogenetic importance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788281      PMCID: PMC1506326          DOI: 10.1136/bmj.283.6286.265

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods.

Authors:  I M Nilsson; T B Kirkwood; T W Barrowcliffe
Journal:  Thromb Haemost       Date:  1979-12-21       Impact factor: 5.249

2.  Phenformin and ethyloestrenol in recurrent venous thrombosis.

Authors:  I M Nilsson; U Hedner; S Isacson
Journal:  Acta Med Scand       Date:  1975 Jul-Aug

3.  Histochemistry and assay of plasminogen activator.

Authors:  M Pandolfi
Journal:  Rev Eur Etud Clin Biol       Date:  1972-03

4.  Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.

Authors:  U Hedner; I M Nilsson; C D Jacobsen
Journal:  Scand J Clin Lab Invest       Date:  1970-06       Impact factor: 1.713

5.  "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.

Authors:  B R Robertson; M Pandolfi; I M Nilsson
Journal:  Acta Chir Scand       Date:  1972

6.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.

Authors:  S Isacson; I M Nilsson
Journal:  Acta Chir Scand       Date:  1972

7.  Thrombosis and oral contraceptives: possible predisposition.

Authors:  B Astedt; S Isacson; I M Nilsson; M Pandolfi
Journal:  Br Med J       Date:  1973-12-15

8.  Effect of ethyloestrenol on fibrinolysis in the vessel wall.

Authors:  U Hedner; I M Nilsson; S Isacson
Journal:  Br Med J       Date:  1976-09-25

9.  delta 4-ethylestrenol in recurrent deep venous thrombosis.

Authors:  B Nilsson; I M Nilsson; U Hedner
Journal:  Acta Med Scand       Date:  1981

10.  Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis.

Authors:  L Johansson; U Hedner; I M Nilsson
Journal:  Acta Med Scand       Date:  1978
  10 in total
  6 in total

1.  Venous gangrene of the upper extremity.

Authors:  B M Smith; G W Shield; D H Riddell; J D Snell
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

2.  Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile.

Authors:  R Sawaya; M Zuccarello; M Elkalliny; H Nishiyama
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

3.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

Authors:  I M Nilsson; H Ljungnér; L Tengborn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

Review 4.  Clinical disorders of fibrinolysis: a critical review.

Authors:  R B Francis
Journal:  Blut       Date:  1989-07

5.  [Post traumatic thrombosis of the subclavian vein without right clavicle fracture: report of a case].

Authors:  Youssef Bibiche; Nabil Kanjaa
Journal:  Pan Afr Med J       Date:  2015-03-17

6.  Fibrinolytic response to standardized venous occlusion in different age groups.

Authors:  S Y Hong; S J Pyo; M H Kim; S K Kim; I S Park; D Y Oh; S J Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.